Cargando…

Development of a Discriminative Dissolution Method, Using In-Silico Tool for Hydrochlorothiazide and Valsartan Tablets

Hydrochlorothiazide (HTZ) and Valsartan (VAL) are poorly soluble drugs in BCS classes IV and II. This study aimed to develop a method to assess the dissolution profile of tablets containing HTZ (12.5 mg) and VAL (160 mg) as a fixed-dose combination, using in silico tools to evaluate products markete...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leon, Rosmery Merma, Issa, Michele Georges, Duque, Marcelo Dutra, Daniel, Josiane Souza Pereira, Ferraz, Humberto Gomes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301187/ https://www.ncbi.nlm.nih.gov/pubmed/37376183 http://dx.doi.org/10.3390/pharmaceutics15061735

Ejemplares similares

Development of Biopredictive Dissolution Method for Extended-Release Desvenlafaxine Tablets
por: Carapeto, Gustavo Vaiano, et al.
Publicado: (2023)

In Silico Prediction of Plasma Concentrations of Fluconazole Capsules with Different Dissolution Profiles and Bioequivalence Study Using Population Simulation
por: Duque, Marcelo Dutra, et al.
Publicado: (2019)

Simultaneous Determination of Valsartan and Hydrochlorothiazide in Tablets by RP-HPLC
por: Tian, D. F., et al.
Publicado: (2008)

HPTLC Method for the Simultaneous Estimation of Valsartan and Hydrochlorothiazide in Tablet Dosage Form
por: Shah, N. J., et al.
Publicado: (2009)

Development of Extended-Release Mini-Tablets Containing Metoprolol Supported by Design of Experiments and Physiologically Based Biopharmaceutics Modeling
por: Issa, Michele Georges, et al.
Publicado: (2022)

Estimation of Amlodipine Besylate, Valsartan and Hydrochlorothiazide in Bulk Mixture and Tablet by UV Spectrophotometry
por: Galande, Varsha R., et al.
Publicado: (2012)

Tablets of “Hydrochlorothiazide in Cyclodextrin in Nanoclay”: A New Nanohybrid System with Enhanced Dissolution Properties
por: Maestrelli, Francesca, et al.
Publicado: (2020)

Effects of Telmisartan with Hydrochlorothiazide versus Valsartan with Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension
por: Marfatia, Ravi, et al.
Publicado: (2012)

Tozinameran/valsartan/hydrochlorothiazide: Pemphigus foliaceus : case report
Publicado: (2022)

Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study
por: Sharma, Arya M, et al.
Publicado: (2007)

Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups
por: Assaad-Khalil, Samir Helmy, et al.
Publicado: (2015)

Development and Validation of New Discriminative Dissolution Method for Carvedilol Tablets
por: Raju, V., et al.
Publicado: (2011)

Development and Validation of Discriminating and Biorelevant Dissolution Test for Lornoxicam Tablets
por: Anumolu, P. D., et al.
Publicado: (2015)

Baboon syndrome (SDRIFE) after valsartan/hydrochlorothiazide intake for several years
por: Tchernev, Georgi, et al.
Publicado: (2021)

Comparative Efficacy of Irbesartan/ Hydrochlorothiazide and Valsartan/Hydrochlorothiazide Combination in Lowering Blood Pressure: A Retrospective Observational Study in Oman
por: Al Balushi, K.A., et al.
Publicado: (2013)

Spectrophotometric Estimation of Olmesartan Medoxomil and Hydrochlorothiazide in Tablet
por: Rote, A. R., et al.
Publicado: (2010)

Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients
por: Destro, Maurizio, et al.
Publicado: (2010)

Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update
por: Destro, Maurizio, et al.
Publicado: (2010)

Role of triple fixed combination valsartan, amlodipine and hydrochlorothiazide in controlling blood pressure
por: Doménech, Monica, et al.
Publicado: (2010)

Comparative effects of valsartan plus cilnidipine or hydrochlorothiazide on nocturnal home blood pressure
por: Fujiwara, Takeshi, et al.
Publicado: (2021)

Metoprolol succinate extended release/hydrochlorothiazide combination tablets
por: Hainer, James W, et al.
Publicado: (2007)

Hydrochlorothiazide/Losartan Potassium Tablet Prepared by Direct Compression
por: Luo, Qiuhua, et al.
Publicado: (2022)

Effectiveness of initiating treatment with valsartan/hydrochlorothiazide in patients with stage-1 or stage-2 hypertension
por: Zappe, D H, et al.
Publicado: (2010)

Impact of Sex and Genetic Variation in Relevant Pharmacogenes on the Pharmacokinetics and Safety of Valsartan, Olmesartan and Hydrochlorothiazide
por: Soria-Chacartegui, Paula, et al.
Publicado: (2023)

Development and Validation of Discriminative Dissolution Method for Metformin Immediate-Release Film-Coated Tablets
por: Mitrevska, Ivana, et al.
Publicado: (2019)

Ion Pair-HPLC Method for the Simultaneous Estimation of Quinapril and Hydrochlorothiazide in Tablets
por: Gandhimathi, M., et al.
Publicado: (2009)

Design and optimization of bilayered tablet of Hydrochlorothiazide using the Quality-by-Design approach
por: Dholariya, Yatin N, et al.
Publicado: (2014)

Simultaneous analysis of eprosartan and hydrochlorothiazide in tablets by high-performance liquid chromatography
por: Patel, Harsha U., et al.
Publicado: (2011)

In vitro and in vivo postmarketing surveillance of valsartan, alone or in combination with amlodipine or hydrochlorothiazide, among Palestinian hypertensive patients
por: Zaid, Abdel Naser, et al.
Publicado: (2016)

Simultaneous determination of amlodipine, valsartan and hydrochlorothiazide by LC–ESI-MS/MS and its application to pharmacokinetics in rats
por: Gadepalli, Shankar Ganesh, et al.
Publicado: (2014)

Application of an LC–MS/MS method for the analysis of amlodipine, valsartan and hydrochlorothiazide in polypill for a bioequivalence study
por: Shah, Jaivik V., et al.
Publicado: (2017)

Influence of the Efavirenz Micronization on Tableting and Dissolution
por: Pinto, Eduardo Costa, et al.
Publicado: (2012)

Evaluation of effectiveness and safety of amlodipine/valsartan/hydrochlorothiazide single-pill combination therapy in hypertensive patients: an observational study
por: Hagendorff, Andreas, et al.
Publicado: (2014)

Derivative and Q-analysis Spectrophotometric Methods for Estimation of Hydrochlorothiazide and Olmesartan Medoxomil in Tablets
por: Bhusari, K. P., et al.
Publicado: (2009)

A Validated RP-HPLC Method for Simultaneous Estimation of Nebivolol and Hydrochlorothiazide in Tablets
por: Meyyanathan, S. N., et al.
Publicado: (2008)

Control of Drug Dissolution Rate from Film Dosage Forms Containing Valsartan
por: Murata, Yoshifumi, et al.
Publicado: (2016)

Influence of Experimental Conditions on Electronic Tongue Results—Case of Valsartan Minitablets Dissolution
por: Wesoły, Małgorzata, et al.
Publicado: (2016)

24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertension
por: Lacourcière, Y, et al.
Publicado: (2011)

A critical appraisal of the clinical effectiveness of a fixed combination of valsartan, amlodipine, and hydrochlorothiazide in achieving blood pressure goals
por: Laffer, Cheryl L, et al.
Publicado: (2011)

Economic evaluation of a single-pill triple antihypertensive therapy with valsartan, amlodipine, and hydrochlorothiazide against its dual components
por: Stafylas, Panagiotis, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mhc5ij9grhp8ft415gh575u5gk